>

MEETINGS / EVENTS

RSS

November 08 - 09 2014, 12:00 AM - 12:00 AM

ASA Quality Meeting 2014

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

>

FDA MEDWATCH ALERTS

October 20, 2014

Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose, Preservative-Free, by Hospira: Recall - Particulate Matter

Summary:

FDA Medwatch Alert 10-20-14

October 16, 2014

FDA MedWatch - LifeCare Flexible Intravenous Solutions by Hospira, Inc.: Recall - Potential for Leakage

Summary:

FDA MedWatch LifeCare Flexible Intravenous Solutions by Hospira Inc

October 13, 2014

FDA MedWatch - CareFusion EnVe and ReVel Ventilators: Class 1 Recall - Power Connection Failure

Summary:

FDA MedWatch CareFusion EnVe and ReVel Ventilators

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

US Supreme Court Schedules Oral Arguments in Case Seeking to Halt FTC Overstep

Tuesday, July 22, 2014

Last week the U.S. Supreme Court announced on October 14 it would hear arguments in North Carolina State Board of Dental Examiners v. Federal Trade Commission (FTC). Under review is a federal appellate court’s decision to uphold a FTC order that the North Carolina State Board of Dental Examiners violated federal antitrust laws when it issued cease and desist letters to non-dentist teeth-whitening providers in the state. At issue is whether the antitrust "state action doctrine" protects the work of state licensure boards. In 2013 and 2014, the American Society of Anesthesiologists (ASA) joined the American Medical Association, the American Dental Association, and other health care groups in friend of the court (amicus) briefs submitted before the U.S. Supreme Court concerning the FTC case.

In correspondence and a face-to-face meeting, the ASA has previously expressed concern to the FTC about the Commission’s letters to state medical boards and legislatures, prompting boards and legislatures to take action contrary to patient safety. Beyond the amicus briefs, this April the ASA submitted formal comments to the FTC strongly urging the agency to modify its current position on the application of the state action doctrine to state licensing authorities and end its related enforcement policies against those agencies. The comments further detailed the importance of states regulating health professionals, which promotes competition that leads to high quality care and the protection of patient safety.

Previous ASA letters

2014 Amicus Brief: NCBDE v. FTC

2013 Amicus Brief: NCBDE v. FTC

ASA Comments to FTC on Health Care Competition 

ASA letter to FTC on role of physician anesthesiologists treating chronic pain

« Back to Washington Alerts